Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response
Epilepsia · 2025
DOI: 10.1111/epi.18297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Itai Loushy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Anticonvulsants, Carbamates, Chlorophenols, Seizures. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Objective
This study assesses the efficacy, safety, and tolerability of cenobamate using long‐term real‐world data, incorporating both seizure reduction and seizure‐freedom periods, and examines baseline clinical variables to determine predictors of response.
Methods
We retrospectively analyzed all patients prescribed cenobamate from May 2020 to July 2021. The primary outcome was 12‐month seizure frequency reduction for each seizure type, stratified by baseline seizure frequency (higher vs lower frequency: ≥2 seizures vs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Jefferson Comprehensive Epilepsy Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- EEG and Epilepsy Unit, Department of Neurology, Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
- Department of Neurology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Psychological and Brain Sciences, Drexel University, Philadelphia, Pennsylvania, USA.
- Department of Neurology, Columbia University Medical Center, New York, New York, USA.
ORCID-Profile: Itai Loushy, Lilach Goldstein, Juan Luis Alcala-Zermeno, Michael R Sperling
Zitieren
APA
Loushy, I., Goldstein, L., Devlin, K., Volski, A., Fletman, E., Alcala-Zermeno, J. L., Porreca, L., & Sperling, M. R. (2025). Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response. Epilepsia. https://doi.org/10.1111/epi.18297
Vancouver
Loushy I, Goldstein L, Devlin K, Volski A, Fletman E, Alcala-Zermeno JL, et al. Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response. Epilepsia. 2025. doi:10.1111/epi.18297
BibTeX
@article{Loushy2025,
author = {Loushy, Itai and Goldstein, Lilach and Devlin, Kathryn and Volski, Anna and Fletman, Elizabeth and Alcala-Zermeno, Juan Luis and Porreca, Louis and Sperling, Michael R},
title = {Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18297}
}
EUVIMED